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Patent Application Preparation 
and Filing
Mohamad Taleuzzaman and Iqra Rahat
Abstract
The issuance of a patent by the government office is basically done by a patent 
application record that is an agreement between the inventor and the govern-
ment office. Correspondingly, a patent application is in many ways like a contract. 
Preparation of a standard patent application is curious because it sets out in a 
transparent way, the terms and condition by which the patent owner and oth-
ers will be bound. These criteria of the patent application make it different from 
writing a scientific paper. The technical subject matter that is available in the patent 
application have bear some similarities to a scientific or technical paper, although 
it does not usually need to rise to the level of a blueprint for making the invention 
protected by the patent. Public officials of government take a long time to review 
the patent as examiners and judges and business partners. Therefore it is necessary 
that a patent application should be drafted with these important audiences in mind. 
The parts of the patent application typically include the Background, Summary, 
Detailed Description and Drawings, Claims, and Abstract. The patent agent is 
unlikely to draft the patent application in this order and should ordinarily draft the 
claims first.
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1. Introduction
From last many decades, national and international organizations have made 
to try with best efforts to homogenize the laws governing intellectual property. 
To attempt the standardization, the little bit restriction always comes it is either 
infrastructure or capital, especially in pharmaceutical industries. That is the reason 
a continuous tension exists in multinational pharmaceutical companies (MNCs) 
in developing nations. Intellectual always give their maximum efforts to overcome 
these problems which the easier business environment worldwide. In the World 
Trade Organization (WTO) earlier, India does not recognize product patents in 
pharmaceutical. Without product patents, Indian pharmaceutical companies were 
able to agitate countless generic drugs. In the world, India contributes to leading 
manufactures in generic drugs. Results of these are that the relative moderate of 
these generic drugs as compared to patented drugs not only provide chief drugs but 
also made India the de facto pharmacy for many developing countries [1].
The basic object of the Intellectual Property Right (IPR) to deliver unquestion-
able absolute right over the fabrication of the mind and to finite exploit it for a fixed 
duration of time, in order to enable them to gather commercial benefits from their 
creative efforts.
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The application and filing is the first step to patent the drugs for trade world-
wide, which provide a platform for the exclusively business without a doubt or 
question regarding the quality of drugs and its efficacy. The evolution of innovation 
can explain by the diagram [1, 2] (Figure 1).
The Intellectual property known as IP, gives the right to the people to own their 
innovation, invention, and creativity in the same way as they own their physical 
property. In can cover the different forms like Figure 2.
In a general way, IPR plays an important role in two principal areas which 
impact in the Pharmaceutical Industry. First, the pricing and access where the focus 
on securing competitive marketing which creates the problems in the pricing of 
drugs. Second, is an issue related research and development incentive, which is the 
marketing of the new medicines and its price? The consequence of IPRs on R&D 
expenditure and its grant across the different disease, countries, and organization.
The IPRs patent application preparation and filing, the right of legal work it 
might be sold, uses, offers for sale and/or imports any technology can be protected 
by the IPR documents, that gives the power to trade in an authentic way. The inven-
tors are completely satisfy if he/she has legal documents of IPR. For this, there is a 
process which is followed by the regulatory bodies in every country.
Before, the patent approved a step that is called the provisional application in 
some country like the United State of America. The provisional patent application 
duration is 1 year and it provides smoothly, rapidly and affordably got the pending 
status. The patent is ownership for creativity or innovation product protected by 
the patent’s claims. Before revealing the innovative idea the patent application filing 
is necessary. The patent should persuade all legal requirements it covers like time 
limits related to how long the invention was disclosed to the public. Before filing a 
patent application if the inventions communicate in public it will be denied without 
any grace period [2–4].
A detailed audit is a must before filing the application itself. From this conse-
quence the broader concept or the principle which are important for the public and 
it will be drafted in very well manner. The application prepares on the facts of the 
principle or new idea that is highlighted in the drafts, its importance, and scope in 
that respective field.
Figure 1. 
Evaluation of IPR.
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In facts, patents are “regional” its consideration only on those countries where 
they have been applied for and granted. Every country has its own legal office where 
it documented that the patent applicability is worldwide or it is only to its own 
country. Patent acceptability and its innovative idea can be challenged and if it’s 
finding any demerits should be rejected. To maintain the discipline and hierarchy in 
the legal office the team must examine the whole content of the application prop-
erly, so further it is no possibility of challenge.
After World War II, The international pharmaceutical Industry grows rapidly. 
The demands of antibiotics create a challenge for the company in the research and 
development division. As the year gone following the wars saw the rapid growth 
in number industry and establish as MNCs by infiltration in many countries. The 
headquarters of such MNCs established in developed countries from where business 
manage. Due to the lack of trained skill human source in developing countries as 
well as a necessary technology for which big capitals are required to developed a 
new molecule make not a possibility such corporation.
After independence India was faced many challenges like as one of the poorest 
countries in the world, with also increase problems in the health sector to overcome 
this government takes any initiative for the amendment in patent law which make 
the business easy. For this government of India appoint two committees one is 
the Patent Enquire Committee (1948–1950) and the Patents Revision Committee 
(1957–1959). The object was to review the patent law and ensure that the patent 
system was more conducive and interest for the nation.
India by 2020 reached as a global leader in the field of the pharmaceutical 
industry. This country established as a leader of generic drugs manufacturers. 
India passed its first patent law in 1856 under the British colonial rule and it is 
based on the British Patent Law of 1852, here inventors have right for 14 years 
duration privileged. In 1911, the British government introduces the Indian Patents 
and Design Act with removing the Inventions and Designs Act of 1888 which is 
effective till 1972.
Worldwide the developing countries as a consumer for the many products its 
importance partly increase, in 1994 all members of the World Trade Organization 
were required to adopt the Trade Related Intellectual Property Standards (TRIPS).
By growing the Pharmaceutical MNCs worldwide, The World Trade 
Organization came into existence on 1 January 1995, and along with it came the 
Trade-Related Aspects of Intellectual Property Rights TRIPS Agreement. Covering 
the international instruments for strengthens the IPR. India initially not in favor 
Figure 2. 
Different types of IPR.
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of TRIPS as other developing countries. As a member of WTO India modifies its 
domestic intellectual property laws in order to comply with the agreement.
In the world, the most difficult aspect of the World Trade Organization’s 
Agreement on Trade-related Aspects of International Property Rights (TRIPS) is 
over the issue of patents for pharmaceutical drugs. From 1 January 1995, The TRIPS 
agreement come into effect, this agreement stretches the scope of intellectual 
property rights. Patents shall be available for any invention it declared in article 
27, whether the products or process in all fields of technology. In India Parliament 
granted by act 1970 that patent rights only to manufacturing processes, rather than 
to the end products themselves,”
In the world, India is the country which not only a chief exporter of drugs but 
also the primary producer of drugs for its own population. Generic drug share 
market is large portion covered by this country [1–3].
2. Patent basic
The basic aspects of the patent system must know very well and it is outlined 
before to practical aspects. The primary logic behind the generation of a patent 
system was to honor an inventor by a full right to the invention of duration for a 
number of years it depends upon the country legal authority. The new inventions 
which support to stimulate and promote the further technological process and 
innovation, it is fruitful when the patent has public access. The countries or group 
of countries have legal authority that patent is the exclusive rights for the innova-
tions. In a trade or commercial business, a patent provides their owners which 
stop from the making, using, offering for sale, selling or importing a product or 
a process without their permission (a license). By the patent system, it is clear 
that how the inventor can protect their patent and also it is necessary that how to 
respect other innovation by participating in it. Keep in mind that the patent itself 
is a regional right, it workable in limited either in a country or a group of countries. 
Patent never is “world patent” as it only territorial. Therefore the filing of a patent 
is a choice of the territory and the region where the patent protected. The desire 
of territory is based on the country market potential, manufacture’s competitor 
place, research center place, and various other places. It is a fundamental part of 
the patent application filing. The basic criteria of patentability—Must be patentable 
subject matter in US geography, Unity of invention, capable of industrial applica-
bility. In most of the countries, the primary object is the novelty, in some countries 
also seen the double standard of novelty depending on the place of the invention 
it is inside the territory or outside the territory. The comparison of novelty and art 
of skill in the invention should be superior to the existing patent in the same field. 
In a patent, the non-obviousness is one of the most difficult things to define. Its 
contribution to defining the level of technology. The examiner of the patent has the 
ability to disclose in the prior art but also identifies the art of the skill in the inno-
vative person. In the Pharmaceutical world, patent protection is very important 
which uplift the development of the new medicine for disease those consequences 
these countries. The patent protection boosts the pharmaceutical industry for 
the investment of the billion to develop the new molecules, making sure that the 
product sale [3, 4].
The pharmaceutical product takes a very long time to develop and enter the 
market for human use. A new dosage form an average takes around 10–15 years 
during this period medicine efficacy and safety must be proved by a different 
phase of a clinical trial. A significant period lost the new drug before entering 
the market that is a disadvantage in the pharmaceutical field. On innovation 
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patent role is that it protect the innovation it either territorial or global, but in 
case of pharmaceutical product, there must be some extent of flexibility by which 
the monopoly right decrease so that it does not affect the cost of medicine. The 
world moving towards the differential pricing of medicines, making the cost of 
medicine cheaper in developing countries. From the developing countries, the 
revenue generated is very less and around 1% as compared developed countries. 
Developing countries contribute the minimum incentive to the research, it comes 
maximums from the developed countries. To provide the health patent is not 
only the obstacle along with it has other factors like poor infrastructure lack of 
sanitation and shortage of funding for even generic drugs Figure 3 (New drug 
development).
The concept behind the patent for innovation is a contract on a temporary basis, 
where society agrees to the monopoly that allowing a high level amounts that doing so 
provide will provide a strong incentive for innovation. Creating revenue from manu-
facturers and production give the strong back up to research and development also 
encourage in the interest in development for the new molecule in pharmaceutical. A 
balance is necessary between the research and development in aspect to economic, 
because from research and development there is no scope to generate direct revenue 
from the customer. Indirectly it gives very strong revenue to the market [4, 6].
3. Structure of application
For filling of application, the ideal requirements of the patentability and also 
the application must be filed by the competent authority for a certain country or a 
group of countries. A quick focus must be given when filing the application and try 
to cover the application with the following parts.
a. Claims
b. Detailed description (or specification)
c. Drawings
d. Background
Figure 3. 
New drug development.
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e. Abstract
f. Summary
Who that file the application; the title must be itself descriptive and creative. 
The title properly indicates the subject matter of the application. The patent appli-
cation itself should also include all priority information, such as the identification 
of related applications. The audience for the application basically is the judges and 
patent examiner. Also, apart from these the patent agent’s client and the inventor 
are also audiences.
3.1 Claims
In the patent filing, the claims for the inventor prepared by the agent that is first 
it must be easy in language and plan should be in at least three. The patent agent 
outlines a diagram in the first disclosure meeting and discusses with the inventor. 
The language or the terminology used for the filing the might be difficult to under-
stand by the inventor. So, the agent explains it in pictures or another diagram by 
which it is easy to understand.
In practice, the agent prepares the several drafts for the communication and select 
the best one for further proceeding. The clam is the legal part of the application. For 
the preparation of quality contents draft, the agent must give the time and during 
writing focus on that, it is concise and explanatory. In any case, it is seen that due to 
short of time the ideal paper not prepare and such situation the technical paper of the 
inventor consider a claim. For convenient the claim may present in a picture that is 
easy to understand. By pictures language the novelty of the paper is high.
As the claims completed the patent agent require to check the specification to 
verify and confirm that the claim terms appropriately explain in the paper.
The detailed description section, sometimes known as the “preferred embodi-
ment of invention” section or the “disclosed embodiment of the invention” section 
breathes life into the claims and provides a sufficient explanation of the invention 
for an ordinary person skilled in the art to make and understand the invention. In 
some jurisdictions, the term “specification” is also used to refer to the description in 
addition to the summary and background sections of the application; suffice to say 
that “detailed description” and “specification” are generally the same for purposes 
of patent drafting.
The detailed description section must be closely tied to the drawings. This 
section cannot be substantively amended once the application has been filed. 
Consequently, the patent agent must make sure that the detailed description section 
provides an appropriate degree of technical disclosure on the day that the applica-
tion is filed as he won’t have a second chance to alter this part of the application. 
The patent agent cannot amend his application to include new technical disclosure 
during prosecution.
If the patent agent uses a highly abstract term in the claims he should consider 
using the term in the detailed description section, but in a manner that ties the 
abstract term to a specific embodiment of the invention. For example, if the claims 
use the term “warning device” for automobile horn, the specification could either 
say: “One example of warning device 10212 is an automobile horn. Other warning 
devices may be used, consistent with the spirit of the invention,” or, “Automobile 
horn 102 constitutes a warning device. Many other such warning devices may be 
used consistent with the spirit of the invention.”
As mentioned above, the detailed description section cannot be substantively 
amended once the application is filed. Thus, a patent agent should take care that 
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the patent application (1) reflects the disclosure material provided by the inven-
tors, (2) provides sufficient information to enable an ordinary artisan to reproduce 
the invention and (3) provides sufficient depth so that the claims can be narrowed 
during patent prosecution to avoid close prior art. Further considerations about the 
scope and importance of the detailed description section will be discussed below 
and are also illustrated by the following example [2, 5, 6].
3.2 Detailed description (or specification)
For the preparation of filing, the specification should be full filling the basic 
requirements. The condition as per the country rule regulation. For example, 
Canadian practices are more or less different from those of American practice. But 
worldwide the American practice is more considering that the Canadian practice 
regarding the specification.
The specification discusses in three parts:
I. Describing the Invention: The first object is to give a hint of what to be 
claimed. Explain the patent by the inventor through the electronic circuit 
compromising a combination of a logic gate. In such a way if the inventor 
wants to file another one application need to only change the logic gate 
where the microprocessor change. Therefore, all claimed elements must 
be shown in the specification. In specification there is no limit, it must be 
broad and require covering most of the points in a general way, where it full 
fill all terms that cover the patent application.
II. Professional Person enables to explain Invention: It is in the concern to 
update software have full knowledge to a patent agent. For convenient, the 
agent explains all the content of the application in drawing with the help of 
updated version of the software. By block diagrams, is easy to understand 
the whole contents of the patent.
III. The Best Mode by the Inventor: The inventor discloses his best knowledge at 
the time of filing of the application. Two ways by which it explains. First, the 
invention carries out as claimed, not disclose invention for commercial in the 
market. The second is subjective here; the inventors may be not disclosing 
the proper knowledge in such case some aspects of the invention in dilemma.
3.3 Drawings
In this part, the presentation of the invention is the best way of drawing which 
makes easy to understand the facts of the invention. The patent agent describes 
the innovative idea with good visual supporting materials. It is found that the 
drawings are the most important of the patent after the claims. The preparation of 
the picture itself an innovative idea, the patent agent first read all the contents of 
the application and thick on the designing of the picture. Some time it is very dif-
ficult to explain the principle or innovative idea by drawing a picture. During the 
explanation of innovation by drawing the agent focus on the using of minimum 
words and that itself explanatory, use in some way a reference in the picture.
3.4 Background
This part is very less important for the filing of the application, the patent agent 
focus on that very least al last. If the background of the application prepares first the 
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value of the draft it finishes. The patent agent trying to explain the background in 
brief. If the background of the patent application describes in detail it is not good for 
the inventor, so some practitioners intentionally not saying too much about the inno-
vation in the background section, in the way patent can be protected in public space.
3.5 Abstract
This section is not necessary here, generally it is described in first or some time 
not requires in a patent application. The innovation idea expresses in very few 
words where it is smartly explained. In some countries, the court demand first 
abstract, by study the abstract the patent application can be understood very easily 
if it is discussed in properly. The preparation of abstract after completing the draft 
of the patent application, if it is prepared earlier, there is a chance of mistake my it 
is poorly written or not completely explanatory. But the drawback of this section is 
that here, some time the innovation specification explains.
3.6 Summary
In most of the country National Law did not ask the legal authority to submit 
the summary, but it comes in practice by the patent agent. Patent agent prepares 
the summary parts with the help of the expert, so it is helpful for the jurisdiction to 
understand what the inventor wants to say. In this section avoid putting the picture 
or explaining the contents thoroughly. The patent agent focuses to write the sum-
mary that it does not explain the parts of the whole claim. The words used in this 
section are not very turning to mean and try to complete in one paragraph [4–6].
4. Patent filling strategy and tools
As it discussed that patents are territorial rights, the designing of the applica-
tion explains itself how the patent protection would be preferable. The filing of the 
patent application is a basic requirement for each country. The grant of a patent and 
thus patent protection is necessary. The filings of application in many countries 
are a financial resource for legal bodies, some it is the uncertainty of the potential 
success of the invention.
During filing the patent agent has the responsibility and accountability to pres-
ent all the information in the given specification that the inventor ownership uses 
their best mode of mechanism to develop for easy access. The chronicle must not 
contain incorrect or confusing statement calculated to cheat the person to whom the 
specification is addressed and make it hard for them, by not considering proper tests 
and experiments, to understand and construct the invention. From the filing of the 
patent, it must be clear that it is useful, certain points relating to its utility must be 
in the specification. The Chronicle may be invalid if it is not properly completed.
It is the duty of the inventor that he or she provides the all information very 
properly to the patent agent of its invention and not hide any information which it 
may be lead to the lawsuit later, which should be legal during the duration of the 
patent. The inventor whatever the content submits to the patent agent either it’s 
in drawing from or in the very good language, the patent agent drafts his or her 
application based on that. The patent agent when preparing the application should 
demand the artwork or the facts from the inventor prior to his work, it may be help-
ful for the agent to draft the application properly. The patent agent put the proper 
address, correct affiliation and place of work in the application. Which must appear 
in the application? The right of the invention may be individual or its transfer to the 
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company or another one, for such things the patent agent must be written with very 
effectively in the application latter it is not questionable [7, 8].
5. Development and importance in pharmaceutical industry
India’s modern pharmaceutical industry was primarily shaped by Patents act 1970. 
Before that Indian market dominated western Multinational Corporation that con-
trolled over third fourth market basically through imported drugs. At that time most 
of the pharmaceutical product was held by foreign companies and domestic drug price 
was among the highest in the world. An important point of the 1970 patents act was the 
special delivery connects to the pharmaceutical that allowed patent protection only for 
a new method or process of manufactures in the synthesis of a molecule in the Indian 
market. This patent protection was provided for only 7 years for pharmaceuticals.
This robust domestic manufacturing industry for pharmaceuticals stems, in 
part from the 1970 Patents Act effectively encouraging the reverse engineering of 
internationally patented products. If the large price increases that some predicted 
following the adoption of TRIPS were realized, they should be evident in the 
aggregate data. Our primary identifying assumption is that the timing of patents 
being granted was orthogonal to other events that might also have affected the 
market outcomes of newly patented products. To further address concerns regard-
ing heterogeneity in the strength of patents or the importance of the patented 
molecules in the Indian market, we next examine the subset of patent applications 
identified. Perhaps the most direct is a decrease in the number of producers due to 
the increased exit rate of incumbent firms or a lower entry rate of new firms. The 
change in prices can occur without any actual difference in the observed market 
structure. As evidence of the existence of this phenomenon, we note that some of 
the firms receiving patents for molecules never appear in the retail sales data. India 
has granted hundreds of patents to both domestic and multinational firms. This 
represents one of the first attempts to apply an entirely new patent system to an 
existing market of this size and scope. Prior to the new patent system, there were 
many products being sold containing molecules that were patented outside of India 
but were domestically manufactured and sold by a large number of firms [9, 10].
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